MSF calls on G20 leaders to manage the AMR crisis with the right tools, practices and principles

Background:

As a medical humanitarian organization, Médecins Sans Frontières (MSF) witnesses first-hand the public health challenges caused by antimicrobial resistance (AMR) in a wide range of our operational contexts, including antibiotic resistance (ABR), drug-resistant tuberculosis (DR-TB) as well as resistance to treatments for malaria, HIV and other infectious diseases.
 
As the G20 Health Working Group meets in Geneva, Switzerland on the sidelines of (or in the runup to) the 71st World Health Assembly, Médecins Sans Frontières (MSF) is urging the G20 member countries make concrete policy commitments for a global coordinated response to TB as part of the broader AMR agenda. In addition, we encourage the G20 countries to commit to covering the TB R&D funding gap by 2020 and to development and equitable delivery of medicines, diagnostic tools and vaccines that are effective, affordable and suitable to control TB.

A full list of briefing documents and interventions for the 71st WHA can be found here.